Krista Lanctot
- Respiratory syncytial virus (RSV) prophylaxis in special populationsBy Ian Mitchell, Bosco Paes, Abby Li and Krista LanctotIan Mitchell1Paediatrics, University of Calgary, Calgary, AB, CanadaBosco Paes2Paediatrics, McMaster University, Hamilton, ON, CanadaAbby Li3MORE, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaKrista Lanctot3MORE, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
- CARESS: The Canadian registry of palivizumab (2005-2010)By Ian Mitchell, Bosco Paes, Abby Li and Krista LanctotIan Mitchell1Paediatrics, University of Calgary, Calgary, AB, CanadaBosco Paes2Paediatrics, McMaster University, Hamilton, ON, CanadaAbby Li3MORE, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaKrista Lanctot3MORE, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
- RSV hospitalization in Down syndrome in the Canadian Registry of Synagis (CARESS) following prophylaxis (2006-2011)By Ian Mitchell, Bosco Paes, Abby Li and Krista LanctotIan Mitchell1Pediatrics, University of Calgary, AB, CanadaBosco Paes2Paediatrics, Mcmaster University, Hamilton, ON, CanadaAbby Li3Sunnybrook Hospital, University of Toronto, ON, CanadaKrista Lanctot3Sunnybrook Hospital, University of Toronto, ON, Canada
- Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011)By Ian Mitchell, Bosco Paes, Krista Lanctot and Abby LiIan Mitchell1Paediatrics, University of Calgary, AB, CanadaBosco Paes2Paediatrics, Mcmaster University, Hamilton, ON, CanadaKrista Lanctot3Sunnybrook Hospital, University of Toronto, ON, CanadaAbby Li3Sunnybrook Hospital, University of Toronto, ON, Canada
- Factors associated with compliance with palivizumab treatment in the Canadian rSV evaluation study for synagis (CARESS) registry (32005-2011)By Ian Mitchell, Bosco Paes, Abby Li and Krista LanctotIan Mitchell1Paediatrics, University of Calgary, AB, CanadaBosco Paes2Paediatrics, Mcmaster University, Hamilton, ON, CanadaAbby Li3Sunnybrook Hospital, University of Toronto, ON, CanadaKrista Lanctot3Sunnybrook Hospital, University of Toronto, ON, Canada
- RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012)By Ian Mitchell, Bosco Paes, Abby Li and Krista LanctotIan Mitchell1Paediatrics, ACH Research Institute/University of Calgary, Calgary, AB, CanadaBosco Paes2Paediatric, McMaster University, Hamilton, ON, CanadaAbby Li3Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaKrista Lanctot3Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
- RSV hospitalization in infants with neuromuscular disease in the Canadian registry of palivizumab after prophylaxis (2005-2012)By Ian Mitchell, Bosco Paes, Abby Li and Krista LanctôtIan Mitchell1Paediatrics/ACH Research Institute, University of Calgary, Calgary, AB, CanadaBosco Paes2Paediatrics, McMaster University, Hamilton, ON, CanadaAbby Li3Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Hospital, Toronto, ON, CanadaKrista Lanctôt3Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Hospital, Toronto, ON, Canada
- Respiratory syncytial virus prophylaxis in Down syndrome: A prospective cohort studyBy Ian Mitchell, Hao Yi, Alexander Kiss, Abby Li, Krista Lanctot, Louis Bont, Beatrijs Bloemers, Michel Weijerman, Chantal Broers and Bosco PaesIan Mitchell1Paediatrics, University of Calgary, Calgary, AB, CanadaHao Yi2Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, CanadaAlexander Kiss2Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, CanadaAbby Li2Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, CanadaKrista Lanctot2Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, CanadaLouis Bont3Department of Pediatrics, Division of Infectious Diseases, University Medical Centre Utrecht, Utrecht, NetherlandsBeatrijs Bloemers3Department of Pediatrics, Division of Infectious Diseases, University Medical Centre Utrecht, Utrecht, NetherlandsMichel Weijerman3Department of Pediatrics, Division of Infectious Diseases, University Medical Centre Utrecht, Utrecht, NetherlandsChantal Broers3Department of Pediatrics, Division of Infectious Diseases, University Medical Centre Utrecht, Utrecht, NetherlandsBosco Paes4Paediatrics, Division of Neonatology, McMaster University, Hamilton, ON, Canada
- Respiratory syncytial virus (RSV) hospitalization in infants with congenital airway anomalies (CAA) in the canadian registry of palivizumab (CARESS) after prophylaxis (2005-2012)By Ian Mitchell, Bosco Paes, Abby Li, Hao Yi and Krista LanctotIan Mitchell1Paediatrics/ACH Research Institute, University of Calgary, Calgary, AB, CanadaBosco Paes2Paediatrics, McMaster University, Hamilton, ON, CanadaAbby Li3Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Hospital, Toronto, ON, CanadaHao Yi3Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Hospital, Toronto, ON, CanadaKrista Lanctot3Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Hospital, Toronto, ON, Canada
- Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizationsBy Candice Bjornson, Parco Chan, Abby Li, Bosco Paes, Krista Lanctot and Ian MitchellCandice Bjornson1Pediatrics, The University of Calgary, Calgary, AB CanadaParco Chan2Pharmacology and Toxicology, The University of Toronto, Toronto, ON Canada3MORE(r) Research Group, Sunnybrook Research Institution, Toronto, ON CanadaAbby Li2Pharmacology and Toxicology, The University of Toronto, Toronto, ON Canada3MORE(r) Research Group, Sunnybrook Research Institution, Toronto, ON CanadaBosco Paes4Pediatrics, McMaster University, Hamilton, ON CanadaKrista Lanctot2Pharmacology and Toxicology, The University of Toronto, Toronto, ON Canada3MORE(r) Research Group, Sunnybrook Research Institution, Toronto, ON CanadaIan Mitchell1Pediatrics, The University of Calgary, Calgary, AB Canada
- Working with families: Lessons from a Canadian registry of palivizumab useBy Ian Mitchell, Parco Chan, Abby Li, Hao Yi, Bosco Paes and Krista LanctotIan Mitchell1Paediatrics, University of Calgary, Calgary, AB CanadaParco Chan2MORE Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON CanadaAbby Li2MORE Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON CanadaHao Yi2MORE Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON CanadaBosco Paes3Paediatrics, McMaster University, Hamilton, ON CanadaKrista Lanctot2MORE Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON Canada
- Respiratory related hospitalizations in premature infants prophylaxed with palivizumab In the Canadian registry of palivizumab (CARESS)By Ian Mitchell, Haben Abraha, Abby Li, Bosco Paes and Krista LanctotIan Mitchell1Paediatrics, University of Calgary, Calgary, AB CanadaHaben Abraha2Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON CanadaAbby Li2Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON CanadaBosco Paes3Paediatrics, McMaster University, Hamilton, ON CanadaKrista Lanctot2Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON Canada
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
